

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.30295847 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30295847 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.94219253 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94219253 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.57136563 |
| 6 | imidazole-containing compound metabolic process (GO:0052803) | 6.57051895 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22270538 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.95979653 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.95979653 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.95979653 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.79465169 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.75925778 |
| 13 | urea cycle (GO:0000050) | 5.72866469 |
| 14 | urea metabolic process (GO:0019627) | 5.72866469 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.58219697 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56931314 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.46148941 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.43390154 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.32868154 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 5.23942104 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.22922384 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.17680321 |
| 23 | protein carboxylation (GO:0018214) | 5.15391006 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15391006 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.10496237 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 4.91922499 |
| 27 | bile acid metabolic process (GO:0008206) | 4.89747348 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.88134041 |
| 29 | cysteine metabolic process (GO:0006534) | 4.85117755 |
| 30 | regulation of complement activation (GO:0030449) | 4.84817515 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.82174514 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.79442219 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.75493705 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.75425702 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.75034568 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.75034568 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.75034568 |
| 38 | phospholipid efflux (GO:0033700) | 4.69300870 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.67868992 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.66191486 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.66191486 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.64141967 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.61047346 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.58608125 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.58608125 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.57946427 |
| 47 | cell migration in hindbrain (GO:0021535) | 4.41279539 |
| 48 | lysine metabolic process (GO:0006553) | 4.39007411 |
| 49 | lysine catabolic process (GO:0006554) | 4.39007411 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.38065394 |
| 51 | response to pheromone (GO:0019236) | 4.37609273 |
| 52 | cholesterol efflux (GO:0033344) | 4.35018939 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.29304833 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.26514167 |
| 55 | regulation of bile acid biosynthetic process (GO:0070857) | 4.23113542 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.22383302 |
| 57 | amine catabolic process (GO:0009310) | 4.19375632 |
| 58 | cellular biogenic amine catabolic process (GO:0042402) | 4.19375632 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.17396226 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.17212565 |
| 61 | cellular glucuronidation (GO:0052695) | 4.16598965 |
| 62 | microtubule severing (GO:0051013) | 4.15697735 |
| 63 | glutamate metabolic process (GO:0006536) | 4.15410739 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.15270835 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 4.10310808 |
| 66 | arginine metabolic process (GO:0006525) | 4.08090715 |
| 67 | glycine metabolic process (GO:0006544) | 4.02925401 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.97600759 |
| 69 | drug catabolic process (GO:0042737) | 3.96734937 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.94762653 |
| 71 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.93724923 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.92975024 |
| 73 | blood coagulation, intrinsic pathway (GO:0007597) | 3.92867470 |
| 74 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92409585 |
| 75 | fibrinolysis (GO:0042730) | 3.91870843 |
| 76 | aldehyde catabolic process (GO:0046185) | 3.86902522 |
| 77 | protein polyglutamylation (GO:0018095) | 3.86650130 |
| 78 | ketone body metabolic process (GO:1902224) | 3.86426559 |
| 79 | opsonization (GO:0008228) | 3.84863746 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.83550657 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.82085347 |
| 82 | establishment of mitochondrion localization (GO:0051654) | 3.76999286 |
| 83 | iron coordination entity transport (GO:1901678) | 3.76527205 |
| 84 | sperm motility (GO:0030317) | 3.76223733 |
| 85 | glucuronate metabolic process (GO:0019585) | 3.76105743 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.76105743 |
| 87 | neuronal ion channel clustering (GO:0045161) | 3.75651098 |
| 88 | complement activation, classical pathway (GO:0006958) | 3.74128356 |
| 89 | acrosome reaction (GO:0007340) | 3.72111024 |
| 90 | protein activation cascade (GO:0072376) | 3.70289247 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.68678022 |
| 92 | cofactor catabolic process (GO:0051187) | 3.68366417 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.68142057 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.67608660 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.65504927 |
| 96 | NAD biosynthetic process (GO:0009435) | 3.65459259 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 3.65096521 |
| 98 | complement activation (GO:0006956) | 3.65011334 |
| 99 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.64556849 |
| 100 | mitochondrion transport along microtubule (GO:0047497) | 3.64556849 |
| 101 | negative regulation of protein activation cascade (GO:2000258) | 3.64530881 |
| 102 | protein-lipid complex assembly (GO:0065005) | 3.63036082 |
| 103 | sterol homeostasis (GO:0055092) | 3.61018043 |
| 104 | organic acid catabolic process (GO:0016054) | 3.60393911 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.60393911 |
| 106 | ethanol oxidation (GO:0006069) | 3.58716886 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.56199587 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 3.55315307 |
| 109 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54333416 |
| 110 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54333416 |
| 111 | cytolysis (GO:0019835) | 3.53617478 |
| 112 | acute-phase response (GO:0006953) | 3.51627191 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.50985598 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 3.41103513 |
| 115 | sperm capacitation (GO:0048240) | 3.26699620 |
| 116 | omega-hydroxylase P450 pathway (GO:0097267) | 3.24988701 |
| 117 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.22608242 |
| 118 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.21054901 |
| 119 | calcium ion-dependent exocytosis (GO:0017156) | 3.17304833 |
| 120 | nucleobase catabolic process (GO:0046113) | 3.13915477 |
| 121 | axon extension (GO:0048675) | 3.13701828 |
| 122 | body morphogenesis (GO:0010171) | 3.12618866 |
| 123 | regulation of ARF GTPase activity (GO:0032312) | 3.06207026 |
| 124 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.05126834 |
| 125 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02714050 |
| 126 | oxidative demethylation (GO:0070989) | 3.01677009 |
| 127 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.00031715 |
| 128 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.99352899 |
| 129 | dendritic spine morphogenesis (GO:0060997) | 2.99066355 |
| 130 | axonal fasciculation (GO:0007413) | 2.98636245 |
| 131 | locomotory exploration behavior (GO:0035641) | 2.96536269 |
| 132 | regulation of respiratory system process (GO:0044065) | 2.93659419 |
| 133 | glutamate secretion (GO:0014047) | 2.89716297 |
| 134 | neuron projection extension (GO:1990138) | 2.88615735 |
| 135 | arginine catabolic process (GO:0006527) | 2.84801611 |
| 136 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.81453968 |
| 137 | neuron recognition (GO:0008038) | 2.80795608 |
| 138 | auditory behavior (GO:0031223) | 2.78816148 |
| 139 | response to acidic pH (GO:0010447) | 2.78282456 |
| 140 | postsynaptic membrane organization (GO:0001941) | 2.77603445 |
| 141 | camera-type eye morphogenesis (GO:0048593) | 2.73906337 |
| 142 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.73356538 |
| 143 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72901977 |
| 144 | positive regulation of action potential (GO:0045760) | 2.69863240 |
| 145 | regulation of microtubule-based movement (GO:0060632) | 2.69048068 |
| 146 | spermatid development (GO:0007286) | 2.68578802 |
| 147 | negative regulation of organelle assembly (GO:1902116) | 2.68294022 |
| 148 | semaphorin-plexin signaling pathway (GO:0071526) | 2.67750554 |
| 149 | response to misfolded protein (GO:0051788) | 2.67017260 |
| 150 | negative regulation of catenin import into nucleus (GO:0035414) | 2.66429672 |
| 151 | regulation of Rab GTPase activity (GO:0032313) | 2.65617306 |
| 152 | positive regulation of Rab GTPase activity (GO:0032851) | 2.65617306 |
| 153 | nephron tubule morphogenesis (GO:0072078) | 2.64290261 |
| 154 | nephron epithelium morphogenesis (GO:0072088) | 2.64290261 |
| 155 | embryonic body morphogenesis (GO:0010172) | 2.62602204 |
| 156 | synaptic vesicle exocytosis (GO:0016079) | 2.61940969 |
| 157 | exploration behavior (GO:0035640) | 2.61804617 |
| 158 | acetyl-CoA metabolic process (GO:0006084) | 2.60018518 |
| 159 | positive regulation of synapse maturation (GO:0090129) | 2.59994110 |
| 160 | cell-cell junction maintenance (GO:0045217) | 2.56779494 |
| 161 | lung epithelium development (GO:0060428) | 2.54537221 |
| 162 | dendritic spine organization (GO:0097061) | 2.54069453 |
| 163 | cranial nerve morphogenesis (GO:0021602) | 2.53159041 |
| 164 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52283942 |
| 165 | neuronal action potential propagation (GO:0019227) | 2.51926133 |
| 166 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.48228456 |
| 167 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.48066609 |
| 168 | synaptic vesicle maturation (GO:0016188) | 2.46967958 |
| 169 | regulation of plasminogen activation (GO:0010755) | 2.46737365 |
| 170 | protein localization to synapse (GO:0035418) | 2.44461644 |
| 171 | metanephric tubule development (GO:0072170) | 2.43716290 |
| 172 | metanephric nephron tubule development (GO:0072234) | 2.43716290 |
| 173 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.42566864 |
| 174 | regulation of action potential (GO:0098900) | 2.41962013 |
| 175 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.41946357 |
| 176 | establishment of monopolar cell polarity (GO:0061162) | 2.40337263 |
| 177 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.40337263 |
| 178 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.39796588 |
| 179 | establishment of protein localization to Golgi (GO:0072600) | 2.39276673 |
| 180 | macroautophagy (GO:0016236) | 2.38612090 |
| 181 | peptidyl-glutamic acid modification (GO:0018200) | 2.38106773 |
| 182 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.37623422 |
| 183 | microtubule bundle formation (GO:0001578) | 2.37536430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.83780854 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.75605515 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.64145479 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.11374489 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.99778330 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.81901642 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.65609451 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55596442 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.46463210 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87831823 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.61733646 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.72701713 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.51950799 |
| 14 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30763379 |
| 15 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23573151 |
| 16 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.15824677 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06407917 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.05314703 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1585754 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.96445648 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94761924 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92289508 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90226934 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88544207 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88529286 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88529286 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84943767 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83168172 |
| 29 | P68_20966046_ChIP-Seq_HELA_Human | 1.82929736 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81984788 |
| 31 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.81566242 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77844371 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77309835 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76634844 |
| 35 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.71822622 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65800712 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.61762152 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60043375 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.57929562 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57081756 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.54269289 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53714212 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.53686009 |
| 44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52726023 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48756849 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46465162 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46129953 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43133840 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42951307 |
| 50 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.40727057 |
| 51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.39090831 |
| 52 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.38143076 |
| 53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36513093 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.36336591 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34749210 |
| 56 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34482130 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34336079 |
| 58 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32458175 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31785762 |
| 60 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.31748630 |
| 61 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.31300270 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29615567 |
| 63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29235633 |
| 64 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.28937199 |
| 65 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28044777 |
| 66 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.27525707 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27401847 |
| 68 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.27113262 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26660325 |
| 70 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.25347761 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23755109 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22903902 |
| 73 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.18914706 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17741219 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17543973 |
| 76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17193498 |
| 77 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.16411167 |
| 78 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.15735135 |
| 79 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13663006 |
| 80 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.13449157 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09069100 |
| 82 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07891020 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07774563 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07236988 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07236988 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07054612 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06926017 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05629407 |
| 89 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04761978 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04426438 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03139181 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01877740 |
| 93 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.00796972 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99871101 |
| 95 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.99830927 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99528762 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99395426 |
| 98 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98927438 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98574642 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98166894 |
| 101 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.96659906 |
| 102 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92459908 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91492204 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91082534 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90987907 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90810894 |
| 107 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.89581454 |
| 108 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89206460 |
| 109 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.88589824 |
| 110 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.88301940 |
| 111 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88083095 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87683723 |
| 113 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.87431159 |
| 114 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.87306062 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83264674 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83218731 |
| 117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83201179 |
| 118 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81404115 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81102305 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79506832 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79506832 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79094422 |
| 123 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78013530 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.75387973 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75068944 |
| 126 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74801318 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72856197 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72549510 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69310041 |
| 130 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68861626 |
| 131 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.68610263 |
| 132 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.68045766 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.66300997 |
| 134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.66057848 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64684120 |
| 136 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64619045 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64550948 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.63691044 |
| 139 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61737701 |
| 140 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.58749300 |
| 141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58726961 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56629512 |
| 143 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56255842 |
| 144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55915737 |
| 145 | VDR_22108803_ChIP-Seq_LS180_Human | 0.55036922 |
| 146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53955473 |
| 147 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.53637159 |
| 148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.53111193 |
| 149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52799783 |
| 150 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.52757060 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52211532 |
| 152 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52096143 |
| 153 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51826107 |
| 154 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51658117 |
| 155 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51534997 |
| 156 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51255215 |
| 157 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50277282 |
| 158 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49905946 |
| 159 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.49786802 |
| 160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.49746250 |
| 161 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.49519597 |
| 162 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.48746629 |
| 163 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48591295 |
| 164 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48531041 |
| 165 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.48362936 |
| 166 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.48174000 |
| 167 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48052663 |
| 168 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.48026531 |
| 169 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.48026531 |
| 170 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.47890375 |
| 171 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.47540475 |
| 172 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.46687933 |
| 173 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46267653 |
| 174 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46211157 |
| 175 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.46063282 |
| 176 | NCOR_22424771_ChIP-Seq_293T_Human | 0.45976442 |
| 177 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.44899674 |
| 178 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44820546 |
| 179 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44095597 |
| 180 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.43851230 |
| 181 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.43731986 |
| 182 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.43566172 |
| 183 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43130844 |
| 184 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42953767 |
| 185 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.42178361 |
| 186 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41965942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.02612071 |
| 2 | MP0005360_urolithiasis | 7.20293875 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.38103757 |
| 4 | MP0005365_abnormal_bile_salt | 5.94007460 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97971895 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.91866318 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.91181082 |
| 8 | MP0003252_abnormal_bile_duct | 3.67701343 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.48868262 |
| 10 | MP0005083_abnormal_biliary_tract | 2.99439153 |
| 11 | MP0009840_abnormal_foam_cell | 2.92720105 |
| 12 | MP0002254_reproductive_system_inflammat | 2.87882170 |
| 13 | MP0003195_calcinosis | 2.82591378 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.75199751 |
| 15 | MP0000566_synostosis | 2.62890417 |
| 16 | MP0005332_abnormal_amino_acid | 2.60475567 |
| 17 | MP0003122_maternal_imprinting | 2.57899948 |
| 18 | MP0003787_abnormal_imprinting | 2.51963159 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.47458698 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.44190452 |
| 21 | MP0005410_abnormal_fertilization | 2.41516433 |
| 22 | MP0003283_abnormal_digestive_organ | 2.36541272 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.35755573 |
| 24 | MP0003880_abnormal_central_pattern | 2.35328989 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.12251731 |
| 26 | MP0000609_abnormal_liver_physiology | 2.11564973 |
| 27 | MP0006292_abnormal_olfactory_placode | 2.10543633 |
| 28 | MP0003868_abnormal_feces_composition | 2.07548800 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.03398058 |
| 30 | MP0002249_abnormal_larynx_morphology | 1.98127503 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.96203937 |
| 32 | MP0001764_abnormal_homeostasis | 1.95439364 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.93655507 |
| 34 | MP0000778_abnormal_nervous_system | 1.90826675 |
| 35 | MP0003878_abnormal_ear_physiology | 1.85354728 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.85354728 |
| 37 | MP0003123_paternal_imprinting | 1.75699503 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.75594452 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.71975728 |
| 40 | MP0009697_abnormal_copulation | 1.69574509 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.69093290 |
| 42 | MP0002572_abnormal_emotion/affect_behav | 1.68694820 |
| 43 | MP0004270_analgesia | 1.68066829 |
| 44 | MP0000955_abnormal_spinal_cord | 1.64374738 |
| 45 | MP0005647_abnormal_sex_gland | 1.60341758 |
| 46 | MP0003121_genomic_imprinting | 1.59384025 |
| 47 | MP0001984_abnormal_olfaction | 1.55358989 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.51865374 |
| 49 | MP0002272_abnormal_nervous_system | 1.45138896 |
| 50 | MP0001970_abnormal_pain_threshold | 1.45112783 |
| 51 | MP0009745_abnormal_behavioral_response | 1.44218896 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.42923583 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42920432 |
| 54 | MP0001486_abnormal_startle_reflex | 1.40100709 |
| 55 | MP0002064_seizures | 1.39956186 |
| 56 | MP0005499_abnormal_olfactory_system | 1.38355305 |
| 57 | MP0005394_taste/olfaction_phenotype | 1.38355305 |
| 58 | MP0005451_abnormal_body_composition | 1.37077082 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.36393783 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.34582912 |
| 61 | MP0002184_abnormal_innervation | 1.33214997 |
| 62 | MP0003698_abnormal_male_reproductive | 1.31975646 |
| 63 | MP0004742_abnormal_vestibular_system | 1.27721855 |
| 64 | MP0002653_abnormal_ependyma_morphology | 1.23968069 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.23471332 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.23345815 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.22972054 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.21410297 |
| 69 | MP0000049_abnormal_middle_ear | 1.20975618 |
| 70 | MP0000534_abnormal_ureter_morphology | 1.20396355 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.18762772 |
| 72 | MP0008569_lethality_at_weaning | 1.17581714 |
| 73 | MP0000003_abnormal_adipose_tissue | 1.14105128 |
| 74 | MP0000026_abnormal_inner_ear | 1.12664979 |
| 75 | MP0003186_abnormal_redox_activity | 1.12237974 |
| 76 | MP0000604_amyloidosis | 1.12058125 |
| 77 | MP0009046_muscle_twitch | 1.11889391 |
| 78 | MP0000685_abnormal_immune_system | 1.11560753 |
| 79 | MP0000598_abnormal_liver_morphology | 1.10863759 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.10650751 |
| 81 | MP0010030_abnormal_orbit_morphology | 1.10291414 |
| 82 | MP0008877_abnormal_DNA_methylation | 1.09328944 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 1.06346952 |
| 84 | MP0004133_heterotaxia | 1.02487415 |
| 85 | MP0000678_abnormal_parathyroid_gland | 1.02478595 |
| 86 | MP0003942_abnormal_urinary_system | 1.00606868 |
| 87 | * MP0009764_decreased_sensitivity_to | 0.99880785 |
| 88 | MP0002234_abnormal_pharynx_morphology | 0.99307097 |
| 89 | MP0009763_increased_sensitivity_to | 0.99160673 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.97593230 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.97253020 |
| 92 | MP0004811_abnormal_neuron_physiology | 0.96690936 |
| 93 | MP0002282_abnormal_trachea_morphology | 0.96281130 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.95347777 |
| 95 | MP0003938_abnormal_ear_development | 0.95038063 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.93270694 |
| 97 | MP0002971_abnormal_brown_adipose | 0.92892627 |
| 98 | MP0002152_abnormal_brain_morphology | 0.92367666 |
| 99 | MP0008789_abnormal_olfactory_epithelium | 0.91474273 |
| 100 | MP0004924_abnormal_behavior | 0.90350110 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.90350110 |
| 102 | MP0003861_abnormal_nervous_system | 0.89638854 |
| 103 | * MP0008469_abnormal_protein_level | 0.89461969 |
| 104 | MP0003011_delayed_dark_adaptation | 0.88663584 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.87179750 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.84971982 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.84451520 |
| 108 | * MP0009642_abnormal_blood_homeostasis | 0.83316688 |
| 109 | MP0002161_abnormal_fertility/fecundity | 0.83217168 |
| 110 | MP0002932_abnormal_joint_morphology | 0.82155805 |
| 111 | MP0005535_abnormal_body_temperature | 0.82015178 |
| 112 | MP0001529_abnormal_vocalization | 0.81886994 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.81626932 |
| 114 | MP0003385_abnormal_body_wall | 0.81616031 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.80865436 |
| 116 | MP0001188_hyperpigmentation | 0.80556589 |
| 117 | MP0003119_abnormal_digestive_system | 0.79318296 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.78916821 |
| 119 | MP0005334_abnormal_fat_pad | 0.76762284 |
| 120 | MP0000751_myopathy | 0.75930561 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.75889290 |
| 122 | MP0003705_abnormal_hypodermis_morpholog | 0.74747735 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.74522995 |
| 124 | MP0001929_abnormal_gametogenesis | 0.74288444 |
| 125 | MP0002116_abnormal_craniofacial_bone | 0.72301137 |
| 126 | MP0004142_abnormal_muscle_tone | 0.71478397 |
| 127 | * MP0009765_abnormal_xenobiotic_induced | 0.71138137 |
| 128 | MP0006082_CNS_inflammation | 0.71062841 |
| 129 | MP0005408_hypopigmentation | 0.70889820 |
| 130 | MP0005448_abnormal_energy_balance | 0.70688949 |
| 131 | MP0003329_amyloid_beta_deposits | 0.70633366 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.69169372 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.68956800 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.68025031 |
| 135 | MP0008872_abnormal_physiological_respon | 0.66025044 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.63990449 |
| 137 | MP0005645_abnormal_hypothalamus_physiol | 0.63348547 |
| 138 | MP0001835_abnormal_antigen_presentation | 0.60404319 |
| 139 | MP0001756_abnormal_urination | 0.60207140 |
| 140 | MP0002837_dystrophic_cardiac_calcinosis | 0.59647048 |
| 141 | MP0000639_abnormal_adrenal_gland | 0.59283299 |
| 142 | MP0003879_abnormal_hair_cell | 0.58889097 |
| 143 | MP0005220_abnormal_exocrine_pancreas | 0.58702671 |
| 144 | MP0005266_abnormal_metabolism | 0.58580987 |
| 145 | MP0003690_abnormal_glial_cell | 0.57592738 |
| 146 | MP0001853_heart_inflammation | 0.57102050 |
| 147 | MP0004510_myositis | 0.55710175 |
| 148 | MP0002735_abnormal_chemical_nociception | 0.51108216 |
| 149 | MP0002822_catalepsy | 0.51094142 |
| 150 | * MP0008874_decreased_physiological_sensi | 0.50671662 |
| 151 | MP0001346_abnormal_lacrimal_gland | 0.49083685 |
| 152 | MP0009053_abnormal_anal_canal | 0.48583997 |
| 153 | MP0004381_abnormal_hair_follicle | 0.46844898 |
| 154 | MP0009115_abnormal_fat_cell | 0.46416011 |
| 155 | MP0003953_abnormal_hormone_level | 0.45882788 |
| 156 | MP0002928_abnormal_bile_duct | 0.45868104 |
| 157 | MP0004782_abnormal_surfactant_physiolog | 0.45003369 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.44281439 |
| 159 | MP0003436_decreased_susceptibility_to | 0.43742002 |
| 160 | MP0001881_abnormal_mammary_gland | 0.43526693 |
| 161 | MP0001348_abnormal_lacrimal_gland | 0.42540095 |
| 162 | MP0005670_abnormal_white_adipose | 0.41799030 |
| 163 | MP0004130_abnormal_muscle_cell | 0.41460359 |
| 164 | MP0004147_increased_porphyrin_level | 0.41226225 |
| 165 | MP0003959_abnormal_lean_body | 0.39922144 |
| 166 | MP0003075_altered_response_to | 0.39709164 |
| 167 | * MP0005464_abnormal_platelet_physiology | 0.39490494 |
| 168 | MP0001845_abnormal_inflammatory_respons | 0.38758924 |
| 169 | MP0005395_other_phenotype | 0.36928110 |
| 170 | MP0001873_stomach_inflammation | 0.36896978 |
| 171 | MP0003724_increased_susceptibility_to | 0.35696767 |
| 172 | MP0006035_abnormal_mitochondrial_morpho | 0.35583549 |
| 173 | MP0002970_abnormal_white_adipose | 0.32183271 |
| 174 | MP0005166_decreased_susceptibility_to | 0.32119769 |
| 175 | MP0003718_maternal_effect | 0.31541970 |
| 176 | MP0001661_extended_life_span | 0.30937291 |
| 177 | MP0000579_abnormal_nail_morphology | 0.30888939 |
| 178 | MP0002796_impaired_skin_barrier | 0.29300630 |
| 179 | MP0001501_abnormal_sleep_pattern | 0.28997559 |
| 180 | MP0008873_increased_physiological_sensi | 0.28809957 |
| 181 | MP0000538_abnormal_urinary_bladder | 0.28529589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.11758875 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.10885803 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.09129430 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.63529452 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30984347 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.25582591 |
| 7 | Xanthomatosis (HP:0000991) | 5.97616178 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.11220437 |
| 9 | Complement deficiency (HP:0004431) | 5.00702650 |
| 10 | Joint hemorrhage (HP:0005261) | 4.71283303 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.60492848 |
| 12 | Hyperammonemia (HP:0001987) | 4.55328862 |
| 13 | Myokymia (HP:0002411) | 4.48603669 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44041781 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.42712446 |
| 16 | Ketosis (HP:0001946) | 4.38658580 |
| 17 | Epidermoid cyst (HP:0200040) | 4.37744489 |
| 18 | Hyperglycinemia (HP:0002154) | 4.20878050 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12760024 |
| 20 | Hyperglycinuria (HP:0003108) | 4.10721462 |
| 21 | Fat malabsorption (HP:0002630) | 4.04222414 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01731647 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.01731647 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.96548266 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.91522804 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91433640 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.86565651 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 3.80823081 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79347596 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68322298 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66302495 |
| 32 | Abnormality of complement system (HP:0005339) | 3.64957666 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.64913515 |
| 34 | Abnormality of the aortic arch (HP:0012303) | 3.59526755 |
| 35 | Ketoacidosis (HP:0001993) | 3.48272990 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.37800962 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.35630021 |
| 38 | Spontaneous abortion (HP:0005268) | 3.22682077 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.18342075 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.09271608 |
| 41 | Turricephaly (HP:0000262) | 3.05835572 |
| 42 | Peritonitis (HP:0002586) | 3.04050775 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 3.03375382 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00901395 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.98263469 |
| 46 | Cholelithiasis (HP:0001081) | 2.97659363 |
| 47 | Abnormal gallbladder morphology (HP:0012437) | 2.97165400 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.92804997 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.92549563 |
| 50 | Steatorrhea (HP:0002570) | 2.90350895 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.78691788 |
| 52 | Acanthocytosis (HP:0001927) | 2.77736760 |
| 53 | Skin nodule (HP:0200036) | 2.76123618 |
| 54 | Myocardial infarction (HP:0001658) | 2.76028159 |
| 55 | Metabolic acidosis (HP:0001942) | 2.68885364 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.68200844 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64958540 |
| 58 | Obstructive sleep apnea (HP:0002870) | 2.60978890 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.60866396 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.60866396 |
| 61 | Mitral stenosis (HP:0001718) | 2.57065541 |
| 62 | Focal seizures (HP:0007359) | 2.56513057 |
| 63 | Renovascular hypertension (HP:0100817) | 2.55983159 |
| 64 | Lymphangioma (HP:0100764) | 2.53761955 |
| 65 | Hyperthyroidism (HP:0000836) | 2.51130060 |
| 66 | Lethargy (HP:0001254) | 2.48093841 |
| 67 | Severe visual impairment (HP:0001141) | 2.47794572 |
| 68 | Amyloidosis (HP:0011034) | 2.47587338 |
| 69 | Gout (HP:0001997) | 2.47525865 |
| 70 | Cerebral edema (HP:0002181) | 2.46878247 |
| 71 | Tubulointerstitial nephritis (HP:0001970) | 2.46489537 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.43844881 |
| 73 | Cholecystitis (HP:0001082) | 2.43844881 |
| 74 | Abnormality of the gallbladder (HP:0005264) | 2.41219340 |
| 75 | Gingival bleeding (HP:0000225) | 2.38571996 |
| 76 | Focal motor seizures (HP:0011153) | 2.36698163 |
| 77 | Neoplasm of the heart (HP:0100544) | 2.36195072 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.35080532 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.34690812 |
| 80 | Vascular calcification (HP:0004934) | 2.32096528 |
| 81 | Shawl scrotum (HP:0000049) | 2.30382792 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29897704 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.29897704 |
| 84 | Glomerulonephritis (HP:0000099) | 2.26548549 |
| 85 | Neonatal onset (HP:0003623) | 2.26375481 |
| 86 | Atelectasis (HP:0100750) | 2.25689529 |
| 87 | Enlarged kidneys (HP:0000105) | 2.24619753 |
| 88 | * Poikilocytosis (HP:0004447) | 2.23524755 |
| 89 | Sleep apnea (HP:0010535) | 2.22513761 |
| 90 | High anterior hairline (HP:0009890) | 2.20258273 |
| 91 | Hypoplastic ischia (HP:0003175) | 2.19721068 |
| 92 | Esophageal varix (HP:0002040) | 2.17781283 |
| 93 | Bell-shaped thorax (HP:0001591) | 2.16272939 |
| 94 | Irritability (HP:0000737) | 2.14330507 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.13900404 |
| 96 | Thrombophlebitis (HP:0004418) | 2.13770855 |
| 97 | Spastic diplegia (HP:0001264) | 2.13717802 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.09733213 |
| 99 | Brushfield spots (HP:0001088) | 2.08823245 |
| 100 | Malnutrition (HP:0004395) | 2.08203266 |
| 101 | Menorrhagia (HP:0000132) | 2.07020079 |
| 102 | Down-sloping shoulders (HP:0200021) | 2.06652699 |
| 103 | Opisthotonus (HP:0002179) | 2.05536978 |
| 104 | Broad metatarsal (HP:0001783) | 2.05514924 |
| 105 | Neonatal hypoglycemia (HP:0001998) | 2.04891945 |
| 106 | Abnormality of dentin (HP:0010299) | 2.04281678 |
| 107 | Amblyopia (HP:0000646) | 2.03462238 |
| 108 | Cardiovascular calcification (HP:0011915) | 2.02889226 |
| 109 | Vomiting (HP:0002013) | 2.01590375 |
| 110 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.01375743 |
| 111 | Pancreatitis (HP:0001733) | 1.99755886 |
| 112 | Genetic anticipation (HP:0003743) | 1.99049511 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97877059 |
| 114 | Nephronophthisis (HP:0000090) | 1.97035751 |
| 115 | Flattened epiphyses (HP:0003071) | 1.94036761 |
| 116 | Hyperglycemia (HP:0003074) | 1.92675486 |
| 117 | Hyperventilation (HP:0002883) | 1.92231008 |
| 118 | Epileptic encephalopathy (HP:0200134) | 1.91851404 |
| 119 | Stage 5 chronic kidney disease (HP:0003774) | 1.91468389 |
| 120 | Thin bony cortex (HP:0002753) | 1.91364901 |
| 121 | Late onset (HP:0003584) | 1.91188776 |
| 122 | Status epilepticus (HP:0002133) | 1.90554647 |
| 123 | Severe Myopia (HP:0011003) | 1.89965968 |
| 124 | Abnormality of the ischium (HP:0003174) | 1.88742503 |
| 125 | Hyperkalemia (HP:0002153) | 1.88124193 |
| 126 | Polycystic kidney dysplasia (HP:0000113) | 1.86665880 |
| 127 | Agitation (HP:0000713) | 1.86375702 |
| 128 | Renal dysplasia (HP:0000110) | 1.84914528 |
| 129 | Rib fusion (HP:0000902) | 1.84096322 |
| 130 | Renal cortical cysts (HP:0000803) | 1.82609607 |
| 131 | Elevated hepatic transaminases (HP:0002910) | 1.82129721 |
| 132 | Hemorrhage of the eye (HP:0011885) | 1.81545966 |
| 133 | Rickets (HP:0002748) | 1.80379767 |
| 134 | Hypercalciuria (HP:0002150) | 1.80364965 |
| 135 | Hypophosphatemic rickets (HP:0004912) | 1.78865801 |
| 136 | Truncal obesity (HP:0001956) | 1.78662700 |
| 137 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.77287876 |
| 138 | Absent epiphyses (HP:0010577) | 1.77287876 |
| 139 | Infertility (HP:0000789) | 1.76770512 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.76721908 |
| 141 | J-shaped sella turcica (HP:0002680) | 1.76133822 |
| 142 | Occipital encephalocele (HP:0002085) | 1.75271235 |
| 143 | Chronic hepatic failure (HP:0100626) | 1.75194220 |
| 144 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.75053740 |
| 145 | Hyperacusis (HP:0010780) | 1.73801409 |
| 146 | Absent/shortened dynein arms (HP:0200106) | 1.73540723 |
| 147 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.73540723 |
| 148 | Shallow orbits (HP:0000586) | 1.73488276 |
| 149 | Increased purine levels (HP:0004368) | 1.73324092 |
| 150 | Hyperuricemia (HP:0002149) | 1.73324092 |
| 151 | Polyphagia (HP:0002591) | 1.73052305 |
| 152 | Impulsivity (HP:0100710) | 1.72984540 |
| 153 | Acute hepatic failure (HP:0006554) | 1.72820572 |
| 154 | Precocious puberty (HP:0000826) | 1.72701906 |
| 155 | Nephritis (HP:0000123) | 1.72542309 |
| 156 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72179043 |
| 157 | Gait imbalance (HP:0002141) | 1.71998615 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71790882 |
| 159 | Bronchomalacia (HP:0002780) | 1.71706408 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.71355520 |
| 161 | Upper limb amyotrophy (HP:0009129) | 1.71355520 |
| 162 | Cystic liver disease (HP:0006706) | 1.70637675 |
| 163 | Male infertility (HP:0003251) | 1.66694737 |
| 164 | Type II lissencephaly (HP:0007260) | 1.66300984 |
| 165 | Truncus arteriosus (HP:0001660) | 1.64344444 |
| 166 | Peripheral hypomyelination (HP:0007182) | 1.64106277 |
| 167 | Hand muscle atrophy (HP:0009130) | 1.63216420 |
| 168 | Abnormality of the renal medulla (HP:0100957) | 1.62315561 |
| 169 | Torticollis (HP:0000473) | 1.61519185 |
| 170 | Abnormality of the corticospinal tract (HP:0002492) | 1.60709363 |
| 171 | Trigonocephaly (HP:0000243) | 1.58999567 |
| 172 | Abnormality of the lower motor neuron (HP:0002366) | 1.58404301 |
| 173 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.56560201 |
| 174 | Aplasia of the phalanges of the hand (HP:0009802) | 1.56560201 |
| 175 | Aplasia involving bones of the extremities (HP:0009825) | 1.56560201 |
| 176 | Supranuclear gaze palsy (HP:0000605) | 1.54560417 |
| 177 | Stridor (HP:0010307) | 1.53837309 |
| 178 | Hypoplasia of the brainstem (HP:0002365) | 1.53622859 |
| 179 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.53622859 |
| 180 | Long palpebral fissure (HP:0000637) | 1.52778154 |
| 181 | Mitral regurgitation (HP:0001653) | 1.51126183 |
| 182 | Ulnar bowing (HP:0003031) | 1.50517507 |
| 183 | Febrile seizures (HP:0002373) | 1.49420953 |
| 184 | Osteomalacia (HP:0002749) | 1.49222330 |
| 185 | Asymmetric septal hypertrophy (HP:0001670) | 1.49097621 |
| 186 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.48587445 |
| 187 | Distal lower limb amyotrophy (HP:0008944) | 1.47776980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.58663445 |
| 2 | FGFR4 | 4.39162876 |
| 3 | ERN1 | 4.13511551 |
| 4 | SIK1 | 4.01265492 |
| 5 | MARK1 | 3.35568293 |
| 6 | MAP3K14 | 2.90995279 |
| 7 | ICK | 2.87565988 |
| 8 | TRIB3 | 2.84065727 |
| 9 | INSRR | 2.73402789 |
| 10 | TAOK3 | 2.67006431 |
| 11 | DAPK2 | 2.62182029 |
| 12 | DDR2 | 2.54098296 |
| 13 | MAP2K4 | 2.54019035 |
| 14 | ERBB4 | 2.50030839 |
| 15 | PRKD3 | 2.36075829 |
| 16 | MAP3K9 | 2.30378618 |
| 17 | TYRO3 | 2.27876854 |
| 18 | NTRK2 | 2.26039819 |
| 19 | MST1R | 2.18554040 |
| 20 | PNCK | 2.06769703 |
| 21 | PIK3CG | 2.02691549 |
| 22 | EPHB2 | 1.92880770 |
| 23 | GRK6 | 1.85654394 |
| 24 | TYK2 | 1.79341173 |
| 25 | CAMK1G | 1.72487514 |
| 26 | LMTK2 | 1.70328699 |
| 27 | BRD4 | 1.67804018 |
| 28 | FLT3 | 1.62490725 |
| 29 | MAPK11 | 1.61935087 |
| 30 | NME1 | 1.59589596 |
| 31 | PLK4 | 1.54663164 |
| 32 | BMPR2 | 1.52187378 |
| 33 | FRK | 1.46184542 |
| 34 | PINK1 | 1.45662903 |
| 35 | JAK2 | 1.45296004 |
| 36 | TESK1 | 1.40417425 |
| 37 | STK38 | 1.37807110 |
| 38 | EPHA3 | 1.36585507 |
| 39 | WNK4 | 1.35794162 |
| 40 | PTK6 | 1.35425123 |
| 41 | TBK1 | 1.35165205 |
| 42 | IRAK3 | 1.33798647 |
| 43 | PKN2 | 1.33002357 |
| 44 | TNK2 | 1.32302721 |
| 45 | RIPK1 | 1.29554232 |
| 46 | AKT3 | 1.27623766 |
| 47 | MAP3K7 | 1.24666715 |
| 48 | EPHA4 | 1.24281659 |
| 49 | ABL2 | 1.23860461 |
| 50 | DYRK2 | 1.23840219 |
| 51 | RPS6KA2 | 1.19183311 |
| 52 | PRKAA2 | 1.17990284 |
| 53 | PDGFRA | 1.15949241 |
| 54 | DYRK1B | 1.13444992 |
| 55 | JAK1 | 1.13299661 |
| 56 | PHKG2 | 1.12945651 |
| 57 | PHKG1 | 1.12945651 |
| 58 | MARK2 | 1.09852364 |
| 59 | MINK1 | 1.09810686 |
| 60 | EEF2K | 1.08916399 |
| 61 | MAP3K13 | 1.08501755 |
| 62 | ARAF | 1.07083064 |
| 63 | UHMK1 | 1.05980665 |
| 64 | NEK9 | 1.05378081 |
| 65 | CAMKK1 | 1.04300044 |
| 66 | MAPK15 | 1.03363624 |
| 67 | CAMK1 | 0.97673590 |
| 68 | IKBKE | 0.97653641 |
| 69 | RIPK4 | 0.96244344 |
| 70 | PRKCZ | 0.95653823 |
| 71 | MAPK12 | 0.95494142 |
| 72 | DMPK | 0.93187135 |
| 73 | GRK5 | 0.91719129 |
| 74 | ERBB2 | 0.89694232 |
| 75 | DYRK3 | 0.87704524 |
| 76 | PRKCQ | 0.86638756 |
| 77 | MAPK4 | 0.86554971 |
| 78 | BRAF | 0.82538803 |
| 79 | MTOR | 0.79787626 |
| 80 | CDK5 | 0.79228784 |
| 81 | EPHB1 | 0.76582497 |
| 82 | MAP2K6 | 0.74745510 |
| 83 | MAPK13 | 0.73244344 |
| 84 | PRKACG | 0.72906918 |
| 85 | FGFR2 | 0.72642056 |
| 86 | PRKD2 | 0.72015893 |
| 87 | MAP2K3 | 0.71380769 |
| 88 | MAP3K11 | 0.70766333 |
| 89 | IKBKB | 0.70575000 |
| 90 | STK11 | 0.70214559 |
| 91 | CAMK1D | 0.69748847 |
| 92 | CAMK2G | 0.69433701 |
| 93 | KDR | 0.68476107 |
| 94 | SGK223 | 0.67597345 |
| 95 | SGK494 | 0.67597345 |
| 96 | PKN1 | 0.66394125 |
| 97 | PRKCH | 0.64976298 |
| 98 | WNK1 | 0.62919357 |
| 99 | CDK12 | 0.62468740 |
| 100 | CASK | 0.60945345 |
| 101 | MAPK8 | 0.60429392 |
| 102 | MAP2K1 | 0.60184798 |
| 103 | STK16 | 0.58847332 |
| 104 | CDK7 | 0.58815999 |
| 105 | MAP3K3 | 0.58370368 |
| 106 | PDK1 | 0.57806584 |
| 107 | PRKCG | 0.57238207 |
| 108 | WNK3 | 0.55043678 |
| 109 | PTK2 | 0.54521303 |
| 110 | RPS6KA6 | 0.54289209 |
| 111 | MAP3K4 | 0.54035903 |
| 112 | SGK2 | 0.53950490 |
| 113 | NEK2 | 0.53872078 |
| 114 | PLK2 | 0.53825985 |
| 115 | MAP3K6 | 0.53426867 |
| 116 | PTK2B | 0.53381318 |
| 117 | RPS6KC1 | 0.53019404 |
| 118 | RPS6KL1 | 0.53019404 |
| 119 | PRKG2 | 0.51963628 |
| 120 | GRK7 | 0.49819617 |
| 121 | MAPK10 | 0.49579359 |
| 122 | CSNK1G2 | 0.48871254 |
| 123 | GSK3B | 0.48596095 |
| 124 | CHUK | 0.48393523 |
| 125 | SYK | 0.48286204 |
| 126 | MAPK7 | 0.48224673 |
| 127 | SIK2 | 0.47735965 |
| 128 | MET | 0.47703170 |
| 129 | KSR2 | 0.47647963 |
| 130 | CDK11A | 0.47456769 |
| 131 | NTRK3 | 0.47331078 |
| 132 | CSNK1E | 0.47278989 |
| 133 | CDC42BPA | 0.46776101 |
| 134 | EGFR | 0.46563801 |
| 135 | BMX | 0.46237978 |
| 136 | PAK6 | 0.46196397 |
| 137 | MAP3K1 | 0.45140674 |
| 138 | SIK3 | 0.45017702 |
| 139 | CCNB1 | 0.44665315 |
| 140 | SGK3 | 0.43666712 |
| 141 | EPHA2 | 0.43405439 |
| 142 | ROCK1 | 0.42894187 |
| 143 | RET | 0.42280293 |
| 144 | GSK3A | 0.40970572 |
| 145 | FGFR3 | 0.40783720 |
| 146 | NTRK1 | 0.39652790 |
| 147 | DYRK1A | 0.38143221 |
| 148 | JAK3 | 0.37910116 |
| 149 | STK38L | 0.37602644 |
| 150 | FGR | 0.37407851 |
| 151 | PDPK1 | 0.36282785 |
| 152 | PRKCA | 0.36204871 |
| 153 | DAPK1 | 0.36126645 |
| 154 | GRK1 | 0.34651058 |
| 155 | CSK | 0.34555704 |
| 156 | IGF1R | 0.33116697 |
| 157 | PRKAA1 | 0.32224959 |
| 158 | PRKCD | 0.32146462 |
| 159 | CAMK2A | 0.30899198 |
| 160 | MAP3K10 | 0.30192969 |
| 161 | ADRBK2 | 0.29710002 |
| 162 | PRKACA | 0.29452728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55706180 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.94231118 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38486981 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26554270 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.16733562 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81728828 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69913707 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61420451 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55548018 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48197867 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42983374 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.38073805 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34910274 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25503385 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18408631 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08922536 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.01388552 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95704049 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91953130 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88319092 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80968238 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80144396 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77193953 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73188325 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.71683213 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71264183 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68419964 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65954820 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65506386 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64071504 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61892253 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58583966 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52176028 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50705867 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47694279 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.46114958 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44718841 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41654240 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40357838 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.39433007 |
| 41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38619371 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36173296 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31132092 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.30591884 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28900901 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.26448299 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23783369 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19449294 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19178951 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18286360 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15659936 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15558334 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 1.14507836 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13267249 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12165793 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09508158 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09394057 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 1.08709671 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08071622 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 1.07819927 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04544587 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03380710 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02590446 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00405390 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93255011 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93007998 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90218026 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89068977 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88830735 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87665434 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82432520 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81916038 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.80241015 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80085809 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79120167 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.78506107 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78450760 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78041195 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72409681 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71527416 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.69991451 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69904050 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65801792 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.65274788 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64097541 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63905092 |
| 87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63593210 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.63550324 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63254643 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62787201 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.62588484 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60952356 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60113269 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58189839 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58111268 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57400384 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57208322 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54366756 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52006139 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50318767 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50056104 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48437570 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48165278 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47982334 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47372378 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46658807 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45663433 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42920965 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42822370 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41227308 |
| 111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36265961 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35254021 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.34609629 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32450673 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25865717 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22567773 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21336708 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18414673 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.15744097 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15414201 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10016383 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.03558387 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.02731184 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02191145 |
| 125 | Asthma_Homo sapiens_hsa05310 | -0.2086352 |
| 126 | Pertussis_Homo sapiens_hsa05133 | -0.2044509 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.1945105 |
| 128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1887065 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1817837 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1788752 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1782433 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1760889 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1751199 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1737530 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1695264 |
| 136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1687717 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1530352 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1371169 |
| 139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1286022 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1226318 |
| 141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0932976 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0848239 |
| 143 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0265496 |

